Concepedia

Sylvia Janetzki

SJ

33

Publications

2.5K

Citations

25

H-Index

1989

Active since

Affiliations

Johannes Gutenberg University Mainz(Current)

Memorial Sloan Kettering Cancer Center

University Medical Center of the Johannes Gutenberg University Mainz

Leiden University Medical Center

Duke Medical Center

Sylvia Janetzki is an author at Johannes Gutenberg University Mainz specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1989–2021

33

Publications

33

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

Jeffrey R. Currier, Ellen Kuta, Lyndsay B Earhart et al. · Journal of Immunological Methods · 2002 · 323 citations

, , +9

Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: A pilot study

Sylvia Janetzki, Dirk Palla, Valentino Rosenhauer et al. · International Journal of Cancer · 2000 · 244 citations · Full text

Response definition criteria for ELISPOT assays revisited

Zoe Moodie, Leah Price, Cécile Gouttefangeas et al. · Cancer Immunology Immunotherapy · 2010 · 226 citations · Full text

, , +18

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

Sylvia Janetzki, Katherine S. Panageas, Leah Ben‐Porat et al. · Cancer Immunology Immunotherapy · 2007 · 200 citations · Full text

Heat Shock Protein Vaccines Against Cancer

Nathalie E. Blachère, Heiichiro Udono, Sylvia Janetzki et al. · Journal of Immunotherapy · 1993 · 153 citations

Rows per page

1–5 of 33